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CAN NANOTECHNOLOGY BE THE LEADING METHOD IN DETECTING 
AND TREATING CEREBRAL TUMORS? 
 





Nanotechnology refers to the manipulation or design of materials and structures with desired 
features in the 1nm–1000 nm size range. The blood brain barrier (BBB) is a major obstacle that 
drugs must overcome in order to reach tumor cells. The role of this barrier is to transport essential 
nutrients while protecting and regulating the internal environment. Nanoparticles have been shown 
to transport drugs through this barrier and accumulate in tumor cells. This is significant since 
nanoparticles are drug carriers allowing chemotherapeutic drugs to accumulate in target areas (Sun 
et al., 2017). This is possible because they are able to be modified to overexpress specific peptides 
or membrane markers that are found in these target areas. Once the nanoparticle reaches these 
anatomical barriers they bind to the correct receptor and move into the area. They can then 
accumulate and drop their payload which may include a chemotherapeutic drug or contrast agent. 
This release is sensed by specific pH or temperature changes (Cheng, Morshed, Auffinger, Tobias, 
& Lesniak, 2014). Nanoparticles can contain different types of elements with unique properties. 
These properties can be optical, magnetic, or thermal resonating (Savale, 2015). They can be used 
in both imaging and treating tumors such as glioblastomas. However, there may be potential side 
effects that are currently not well understood (Wikipedia, 2019b). Nanoparticles are known to have 
a low toxicity when compared to other drugs (Wikipedia, 2019b). However, high toxicity levels 
can lead to alarming effects such as affecting other organs and their function (Savale, 2015). 
Cancer in the brain such as a glioblastoma (GBM) is one of the most active and lethal cancers. 
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Unfortunately, there is no known effective treatment; however, the use of nanoparticles has opened 
a new door into fighting this disease. This paper will discuss the relationships that nanoparticles 
have in treating cerebral tumors as well as imaging of cerebral tumors. 
 
INTRODUCTION 
The treatment and imaging of brain tumors is a difficult challenge faced in the neuro-oncology 
field. Tumors within the brain are very aggressive and usually once removed are able to recur and 
cause further problems in the future. To treat a glioblastoma surgically, margins of the tumor must 
be identified to differentiate diseased tissue from healthy tissue which is difficult without clear 
imaging (Cheng et al., 2014). Secondly, it is difficult for therapeutic drugs to reach target areas of 
tumor cells because of anatomical barriers such as the BBB. As a result, therapeutic drugs that are 
being used today have a difficult time accumulating and even reaching these target areas. In a 
clinical setting, an MRI (Magnetic Resonance Imaging) is used with a contrast media such as 
gadolinium to image a tumor found within the brain (Cheng et al., 2014). However, these 
molecules have a difficult time crossing the BBB because of the tight junctions that regulate what 
may enter and leave the brain. Also, extrusion pumps export drug out of the brain. Contrast media 
that is used in imaging typically depicts the areas where the BBB has been disrupted by the tumor 
cells and not the entire tumor itself. These molecules have a short half-life and usually require 
repeated injections of contrast media at higher doses which may result in harmful side-effects. 
These limitations have resulted in increased research in the neuro-oncology field for better 
techniques in imaging and targeting of brain tumors. Nanotechnology refers to the design, 
synthesis, and application of material within the size range of 1-1000 nanometers. Nanoparticles 
that contain properties such as optical, magnetic, and thermal resonance have gained interests in 
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the medical field and specifically oncology. Nanoparticles may have the opportunity to overcome 
the limitations discussed previously that typical drugs and imaging techniques face. 
 
BACKGROUND OF NANOPARTICLES 
The concept of the uniqueness of nanoparticles first began during a lecture at an American physical 
society meeting named, “There’s Plenty Room at the Bottom,” on December 29th, 1959 by Richard 
Feynman (Nanos, 2019). A Japanese scientist named Norio Taniguchi coined the termed 
nanoparticle in a 1974 conference (Wikipedia, 2019a). An American engineer named Eric Drexler 
was credited for the development of molecular nanotechnology (Nanos, 2019). Over the past few 
years, many kinds of nanoparticles have been produced. During this time, they have been used to 
create nanomaterials (MINATEC, 2016). These nanomaterials have then been used in areas such 
as: transportation, environment, healthcare, new energies, buildings, etc. (MINATEC, 2016). 
Nanoparticles also have physical properties like conductance, uniformity, and optical properties 
that make then useful in science (MINATEC, 2016). 
This paper will focus on its application and abilities to the medical field specifically. 
Nanoparticles have gained interest since they have specific characteristics such as optical 
properties, heat transfer, and a small size (Pall et al., 2019). When light is shined on a nanoparticle 
it is able to be dispersed or absorbed (Aldrich, 2019). This is important for imaging of tumors. 
Heat transfer is another property that nanoparticles hold specifically magnetic nanoparticles (Pall 
et al., 2019).  These particles generate heat once they are stimulated with some type of 
electromagnetic source such as light or a magnetic field (Pall et al., 2019). This property is 
emphasized in a study discussed later in this paper. However, once the particle reaches a tumor 
cell they then heat up and trigger mainly apoptosis (Pall et al., 2019). This can not only help in 
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treating cancers in the brain, but cancer found throughout the body. The small size of nanoparticles 
is discussed throughout this paper; it is very important to understand how their small size relates 
to their function.  
 
STRUCTURE AND FUNCTION OF NANOPARTICLES 
Nanoparticles are not simple molecules; they are complex mixtures (Christian, Von der Kammer, 
Baalousha, & Hofmann, 2008). There are few characteristics that all nanoparticles have in 
common such as they characteristically have a high surface area to volume ratio which play a role 
in why they are effective vehicles in treating and imaging of glioblastomas (Christian et al., 2008). 
Nanoparticles usually have a surface chemistry that differs from its core material (Christian et al., 
2008). The surface of the nanoparticle plays a role in the environment and how it is able to 
transverse through the body. The surface of the nanoparticle also plays a role in its applicability 
and function. For example, the surface of the nanoparticle is where the overexpressed peptides or 
antibodies would be located that are able to specifically bind to certain obstacles like BBB and the 
tumor site. A nanoparticle can essentially be characterized into three layers: a functionalized 
surface, a shell that may be added intentionally depending on its task, and a core material such as 
a specific drug, contrast agent, or a metal (Christian et al., 2008). 
 The surface of a nanoparticle can be modified with the addition of small molecules, 
surfactants, peptides, or polymers. The charge of a nanoparticles surface may be modified allowing 
it to disperse in specific environments. For example, for a nanoparticle to disperse in an aqueous 
solution it must have a charged surface. Nanoparticles that do not have the ability to hold a charge 
on their surface may be modified with the addition of small molecules that are able to covalently 
bind to the surface of a nanoparticle which itself holds a charge. Examples of these molecules 
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include citrate stabilized gold, silver sols, and thiopropanic acid (Christian et al., 2008). The shell 
is the location where peptides are added that bind to receptors and are able to pass through 
anatomical barriers which is discussed in the next section (Christian et al., 2008). 
 The shell is the inner layer between the inner core and the outer surface (Christian et al., 
2008). This layer is usually chemically different than the inner core (Christian et al., 2008). This 
layer may be prepared purposefully or can form through natural processes. An example of this is 
the formation of iron nanoparticles which form layers of iron oxide into their shell after they have 
been prepared (Christian et al., 2008). 
 The core of the nanoparticle is essentially the center of the nanoparticle. Many 
nanoparticles receive their name for what they hold in their core (Christian et al., 2008). Their core 
is what causes the side effect of nanoparticles such as toxicity. For the topic of neuro-oncology 
this is where the drug, contrast media, or metal is held. 
 
SYNTHESIS OF NANOPARTICLES 
Nanoparticles are synthesized through two different methods: top-down and bottom-up (Arolel, 
2014). The particles are produced from materials such as polymers, lipids, proteins, metals, and 
semiconductors. The top-down method is usually the simplest way of fabricating nanomaterial in 
bulk. (Arolel, 2014). This method consists of mechanical processes known as ball milling in which 
energy of a grinding source is transferred to the substance being reduced. The material can then 
undergo processes known as compaction and consolidation in which it is then put back together 
with better characteristics (Arolel, 2014). There are many other top-down mechanical processes 
such as thermal methods in which heat is included in the form of electricity or solar energy. 
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Another form of a mechanical process is the lithography method (Arolel, 2014). This method 
works by adding patterns to the outside of the nanoparticle (Arolel, 2014). 
The bottom-up approach is when nanoparticles begin as atoms or molecules and undergo 
processes that essentially build them up into functioning nanoparticles. Chemical vapor deposition 
is a common bottom up process that is a gas phase process (Arolel, 2014). This process begins 
with a reactive element which reacts over a templated surface to form a nanostructure. Examples 
of reactive elements used in this process include methane, acetylene, or other reactive carbon 
gases, and their catalysts include cobalt, iron, or nickel (Arolel, 2014). Other known bottom-up 
methods include atomic layer deposition, molecular beam epitaxy, liquid phase methods, and 
electroless deposition. All of these methods follow the same concept as the bottom-up approach 
beginning as small atoms or molecules and built up to larger structures up to 100 nanometers. 
Another process of the bottom-up method is the sol-gel process (Arolel, 2014). The sol-gel process 
is a wet chemical technique that is mostly used in nanotechnology and has multiple steps. These 
steps include hydrolysis and polycondensation, gelation, aging, drying, densification, and 
crystallization. This method is a synthetic way to create metal oxide nanoparticles (Arolel, 2014). 
Sol-gel process has a variety of advantages like easy modification as well as a changeable 
microstructure (Arolel, 2014). 
 
PHASES OF DEVELOPMENT 
Figure 1 depicts various nanoparticles that are being used today such as their uses and phases of 
development (Cheng et al., 2014). Currently there are many possible nanoparticles that are being 
used in treating cancers in the brain. Three main materials used for nanoparticles are organic, 
inorganic, and hybrid (Cheng et al., 2014). Organic materials are formed from particles like 
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liposomes and micelles. Both of these nanoparticles are used for transporting drugs (Cheng et al., 
2014). Inorganic materials are materials like iron oxide and quantum dots. Iron oxide are also used 
as drug carriers but are also used in MRI imaging. Quantum dots are used for florescence imaging 
(Cheng et al., 2014). Hybrid materials are a combination of more than one type of nanomaterial. 
These structures normally form barge or tanker designs (Cheng et al., 2014). A barge design is 
when the entity is stuck onto the outer surface of the nanoparticle. On the other hand, a tanker 
design is when the entity being carried is inside of a porous capsule like structure. Determining 
which design to use is based on what is being transported (Cheng et al., 2014). Delicate drugs that 
are possibly unstable or can easily be altered should be placed in a vessel (tanker) until it reaches 
its destination. In another situation an imaging medium should be placed on the outside of the 
nanoparticle (Cheng et al., 2014). This allows for it to be easily found and used, which is return 
allows for a faster release of the package when met with a stimulus. Unfortunately, both of these 
designs have a common flaw when it comes to carrying capacity. Based on a spherical model, 
more substances can be placed inside of the nanoparticle than can be placed on the surface area. 
The transportation design method used is based on the size of the substance being carried (Cheng 
et al., 2014).  
 




When the nanoparticles are ingested, there are two pathways it can take (Teleanu, Chircov, 
Grumezescu, Volceanov, & Teleanu, 2018). If the nanoparticle is small enough it can pass through 
the empty areas between the cells (paracellular absorption). They can also be taken across cells by 
enterocytes with no energy required or by being bound to specifically instructed receptors (Teleanu 
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et al., 2018). Depending on the size, charge, and the ability to be dispersed, nanoparticles can go 
through the gastrointestinal tract (Teleanu et al., 2018). From here they can be pulled into the 
systemic circulation and get spread out to other organs (Teleanu et al., 2018). If the size is small 
enough these nanoparticles can then cross the BBB and build up in the brain (Teleanu et al., 2018). 
Also, nanoparticles can be engulfed through cell mediated endocytosis where the cells are able to 
recognize the nanoparticle and then take it in through phagocytosis. From here it travels until it 
can reach the BBB.  
B. Inhalation 
Another option for delivering these nanoparticles and their drugs so that they reach the brain is 
thorough inhalation. Once inhaled they will either go to the upper respiratory tract or the lower 
respiratory tract (Oberdörster, Elder, & Rinderknecht, 2009). From either of these two locations 
they will be transported to the lymph and then into the blood, or directly to the blood. Once in the 
blood they will eventually reach the BBB (Oberdörster et al., 2009). Nanoparticles that are in the 
blood were also found to be located in other organs like the liver and spleen (Heath, 2019). Where 
these particles end up is based on their size. The smallest sizes (10nm) are capable of spreading to 
almost all organs (Heath, 2019). Larger nanoparticles (100nm or more) are mainly kept within the 
liver and spleen because they cannot make it through the smaller pores (Heath, 2019). If the 
nanoparticles are hydrophilic based, they will stay inside of the body longer as well as carry a 
positive charge. While held in the spleen and liver these nanoparticles are easily eliminated due to 










C. Skin Absorption 
In this technique the nanoparticle is held within the lipid configuration that the skin has, or in the 
connections of the skin (Teleanu et al., 2018). From here they ideally can be released slowly into 
the deeper skin layers like the dermis (Teleanu et al., 2018). More research and trials need to be 
done with this method (Teleanu et al., 2018). More research will allow for a better understanding 
of what specific nanoparticles can be used in skin penetration as well as which will affect this 
technique (Teleanu et al., 2018). When using this technique there is a possibility of irritation and 
sensitivity to the nanoparticles (Teleanu et al., 2018). This sensitivity and irritation can cause 
allergic reactions from the release of various metals used in the process (Larese Filon, Mauro, 
Adami, Bovenzi, & Crosera, 2015). Research must still be done on nanoparticles used for skin 
absorption specifically the effects of size, shape, surface receptors on how nanoparticles can pass 
through the skin and into the blood stream (Teleanu et al., 2018). 
D. Injection 
Hexapeptide dalargin, the first drug used with nanoparticles, was injected intravenously in 2005 
(Wikipedia, 2019b). This process was a breakthrough for nanoparticle in the medical field. This 
opened the doors for other options and other attempts to be made (Teleanu et al., 2018; Wikipedia, 
2019b). This type of exposure is most used in the field of nanomedicine and used for brain cancer 
and central nervous diseases such as Alzheimer’s, Schizophrenia, and Parkinson’s (Teleanu et al., 
2018). This pathway injects nanoparticles directly into the blood stream and if small enough can 
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MODIFICATIONS TO NANOPARTICLES 
Drugs must be able to overcome the obstacle of the BBB (illustrated in figure 2 and 3) to reach the 
target site (Cheng et al., 2014). As stated before, nanoparticles have gained much attention through 
the capability of adding modifications to their surface. These modifications allow them to 
overexpress particular peptides or antibodies which can then bind to receptors found in the BBB 
or tumor cells allowing them to pass by cell mediated endocytosis. This is a great advantage that 
nanoparticles have over other drugs and imaging techniques. An experiment was done to assess 
the endocytosis efficiency of macrophages loaded with gold nanoparticles. These gold 
nanoparticles were used to kill glioblastoma cells through mainly apoptosis and small amounts of 
necrosis (Pall et al., 2019). Apoptosis is known as programmed cell death. During this time the 
cell begins to break apart and the DNA forming “blebs” or small vesicles where they are located 
are phagocytized by macrophages. However, necrosis is known as abnormal cell death in which 
the small vesicles are formed, but they then fuse with other vesicles and rupture releasing cell 
contents which can result in an unwanted inflammation response. This unwanted response can 
cause major undesirable consequences such as brain damage, coma, or even death (Fellizar, 2018). 
These macrophages were previously known to transverse the BBB which allowed them to 
be recognized and cross the barrier (Pall et al., 2019). NHE9 is a sodium hydrogen exchanger 
which has been known to be a driver for glioblastoma progression (Pall et al., 2019). NHE9 
overexpression had been previously shown to increase accumulation in glioblastoma cells. These 
gold nanoparticles contained NHE9 overexpression on their surfaces which allowed them to 
accumulate in the tumor cells (shown in figure 4) (Pall et al., 2019). Once the nanoparticles had 
accumulated within the tumor cells a new technique known as Gold Nanoparticle Enabled 
Photothermal Therapy (NEPTT) was used (Pall et al., 2019). This technique uses infrared light 
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which the nanoparticles then turn into heat which triggers apoptosis and small amounts of necrosis 
(Pall et al., 2019). This temperature change can be seen in the graph in figure 5 (Pall et al., 2019).  
 
OTHER METHODS OF NANOPARTICLE TRANSPORT  
This paper focuses mainly on how nanoparticles are able to pass through the BBB through cell 
mediated endocytosis. However, figure 3 illustrates other mechanisms for nanoparticles to cross 
the BBB (Pall et al., 2019). Mechanisms worth noting include adsorbtive transcytosis and the 
transcellular lipophilic pathway (Pall et al., 2019). Adsorbtive transcytosis includes the binding of 
cation (positively charged) molecules to the BBB which the brain then recognizes and absorbs 
(Curley & Cady, 2018). The transcellular lipophilic pathway is currently not well understood, 
however this pathway uses lipohilic molecules (loaded with nanoparticles) that are known to be 
able to cross the barrier (Curley & Cady, 2018).  
 
NANOPARTICLES USED FOR DRUG DELIVERY 
Nanoparticles used for drug delivery are natural and biodegradable to reduce the risk of side effects 
and toxicity (Wikipedia, 2019b). Nanoparticles used as drug carriers include; liposomes, micelles, 
polymeric nanoparticles, gold nanoparticles, iron oxide nanoparticles, and ceramic nanoparticles 
(Cheng et al., 2014). These different types of nanoparticles no matter if they’re organic or inorganic 
function in the same way. Nanoparticles high surface area allows them to hold high amounts of 
the chemotherapeutic drugs or contrast media. Many hydrophobic drugs that normally would not 
be able to pass the BBB are able to when used with a nanocarrier. As discussed earlier, 
modifications to the surface of nanoparticles allow for an effective delivery system for brain 
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tumors. Liposomes, spherical phospholipid bilayers have received lots of attention through their 
ability to pass the BBB and enhance the pharmacological effects of the drug.  
 
NANOPARTICLES USED FOR IMAGING 
Research is being done to design nanoparticles that include multiple imaging modalities. Different 
imaging modalities include MRI, PET, optical, and SPECT. Since each modality has its advantages 
and drawbacks, when they are used in combination this may result in a better chance for earlier 
detection and imaging of the tumor cells. These images may help in every step of cancer treatment 
including pre-op, intra-op, and post-op. Many nanoparticles serve as both drug carriers and 
imaging probes such as gold nanoparticles. Gold nanoparticles have surface plasmon 
characteristics. This is caused by oscillations of electron charge that is in resonance with the 
frequency of visible light. The surface plasmon resonance can be determined by the size or shape 
of the nanoparticle. This allows the nanoparticle to be tailored for imaging of specific tumor cells. 
 
IMAGING TECHNIQUES USED IN CONJUNCTION WITH NANOPARTICLES 
A variety of imaging modalities are being used including Magnetic Resonance Imaging (MRI), 
Positron Emission Tomography (PET) (Z. Cheng, Yan, Sun, Shen, & Gambhir, 2016), Optical 
imaging, and single-photon emission computerized tomography (SPECT) (Clinic, 2019). MRI’s 
are precise in imaging and allow for the detection of minute lesions; however, they are at a high 
cost and take longer in time (Cheng et al., 2016). PET scans allow for the imaging of specific 
organs and tissues compared to an MRI which images joints, cartilage, ligaments, and tendons. 
SPECT integrates computer tomography and a radioactive tracer. The tracer allows the ability to 
see where blood is flowing to tissues and organs (Cheng et al., 2016). With the combination of 
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these imaging techniques may allow for earlier detection of cancer and better characterization of 
molecular and metabolic features of a brain tumor (Cheng et al., 2016). 
 
FUTURE WORKS 
Based on what has been learned in this field some problems must be solved in the future. In the 
oncoming years it is expected that there will be the creation of nanodevices that are able to deliver 
to the cancer preventing substances as well as anticancer vaccines (Savale, 2015). It is also 
suggested that molecular sensors that can be implanted should be created to detect biomarkers 
known to be associated with cancer (MEMS). Nanoparticles are also being improved to efficiently 
deliver medication that will help to reduce the side effects from cancer fighting therapies (Savale, 
2015). Better imaging diagnostics such as targeted contrast agents that improve imaging and 
resolution of tumors (quantum dots) (Savale, 2015). Continued research that integrates imaging 
and therapeutic function into nanoparticles (Savale, 2015). To advance this research 
interdisciplinary training from engineering, biology, nanotechnology, and oncology can accelerate 
our understanding of nanoparticles help answer question that are currently not completely 




Many challenges are faced in overcoming the BBB and then targeting of brain tumor cells (Cheng 
et al., 2014). Also, the ability for nanoparticles to target only tumor cells is a difficult task because 
normal cells found in the brain may also express targeted receptors that the nanoparticle is 
modified to attach to (Cheng et al., 2014). Nanoparticles that have shown the most promising 
results are those that express multiple peptides that allow for recognition of tumor cells (Cheng et 
al., 2014). Another challenge that is faced is the control of drug release. For the particle to function 
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optimally it must deliver the drug inside the tumor cells (Cheng et al., 2014). Not only should these 
particles sense change in pH or temperature, but they could also include enzyme degradable 
attachments as well as chemical linkers that are capable of cleaving the particle once it arrives in 
the correct location (tumor cells) (Cheng et al., 2014). Nanotoxicology is a growing subject in the 
medical field because the use of nanoparticles in the medical field has increased in interest and 
possible application. Specifically, safety is a major concern in nanomedicine because the effects 
of these particles are not well known (Cheng et al., 2014). Concerns of applying these particles to 
actual patients start to arise. Nanoparticles are known to have a low toxicity compared to other 
forms of cancer treatment; however, the long-term side effects are not well known (Cheng et al., 
2014). Currently, nanoparticles are being used to treat patients with aggressive recurring 
glioblastomas who have a low quality of life (Cheng et al., 2014). The central nervous system is 
one of the most complex specialized systems in the body, and the use of nanoparticles in the brain 
may be unpredictable and not fully understood when interacting with healthy cells (Cheng et al., 
2014). 
 Nanoparticles are still in the beginning stages of research and are still a relatively new idea. 
Few nanoparticles are being used in clinical trials and on patients with the worst prognoses (Cheng 
et al., 2014).  To fully understand the effects of nanoparticles will require large amounts of studies, 




The use of nanoparticles to treat brain cancer is still a new and emerging field. This idea originated 
in 1959 at a meeting of American physical scientists. After work was done, it was discovered that 
nanoparticles all have a few characteristics in common. All nanoparticles have a large surface area 
and surface chemistry that is different from its core. Nanoparticles are made from two main 
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methods: top-down and bottom-up. Top-down is the easiest and simplest whereas bottom-up is 
when they start off as atoms and are built up to become nanoparticles that can be used. A common 
process of bottom-up is the sol-gel process that is often used in nanotechnology. Currently there 
are three materials that are used for nanoparticles: organic, inorganic, and hybrid. Each of these 
are based on what the particle will be used for. Nanoparticles used in drug therapy can be 
administered in various ways such as ingestion, inhalation, skin absorption, and injection. 
Although nanoparticles are very upcoming and promising there is still work that needs to be done. 
These nanoparticles must be able to overcome the BBB to be effective in administering the drugs. 
Fortunately, these nanoparticles are able to have modifications made to their surface. Overall, 
nanoparticles are a promising idea to use in treating brain cancers, other various diseases, and 
imaging methods. In the future, it is speculated that nanodevices will be created to deliver 
anticancer substances, and molecular sensors will be used in implant form as biomarkers for 
cancer. Not only this, but they will also be constructed to better deliver medications that would 
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This figure depicts the many various types of nanoparticle and importantly for this paper their 
material, applications, and phases of development. Note. From “Multifunctional Nanoparticles for 






















This figure helps in proving the point that the BBB does a great job at protecting itself from foreign 
molecules. Astrocytes as well as pericytes are shown wrapping around the endothelial cells 
forming tight junctions that create a barrier. Note. From “Multifunctional Nanoparticles for Brain 
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Figure 1: This paper focuses on receptor mediated endocytosis; however, nanoparticles have other 
methods of overcoming the BBB. This figure illustrates other methods that are not discussed in 
















This figure depicts the effectiveness of external modifications on nanoparticles. This figure is from 
the study that was previously discussed. As shown when the gold nanoparticles had NHE9 
overexpression they were more likely to be accumulated within the glioblastoma cell (tumor cell). 
The bar graph on the right depicts the measured results from a control compared to a nanoparticle 
with NHE9. As shown, a 12-fold increase can be seen with those expressing NHE9 compared to 
the control with around a 1-fold increase. Note. From “A gain of function paradox: Targeted 
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This figure shows the change in temperature once the gold nanoparticles were accumulated in the 
tumor cells. Gold Nanoparticle Enabled Photothermal Therapy (NEPTT) was used. This used 
infrared light which the nanoparticles then turn into heat which trigger apoptosis and small 
amounts of necrosis. This line graph illustrates the temperature change with gold nanoparticles vs. 
without non-gold nanoparticles. Up to an 18° Celsius temperature change can be seen with gold 
nanoparticles present. Note. From “A gain of function paradox: Targeted therapy for glioblastoma 
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